Abstract
Vaccinia virus (VV) and other pathogenic poxviruses encode for a complement control protein. The VV complement control protein or VCP, was one of the first soluble microbial proteins postulated to have an active role in the immunomodulation of the host defense. Since then, 2 other poxviruses, including variola virus and cowpox virus (CPV), were found to have corresponding proteins. Based upon earlier studies which demonstrated the role of the CPV complement control protein in modulating the specific tissue responses in BALB/c and congenic-matched C5-sufficient and C5-deficient mice [1], the CPV equivalent has been renamed the inflammation modulatory protein (IMP), so as to specifically reflect its function. In this study, the in vivo cellular response of mice injected with CPV or a recombinant virus lacking the IMP sequence (CPV-IMP) was examined using a connective tissue air pouch model. Microscopic examination revealed that CPV-IMP caused a significant mononuclear cell infiltration into the connective tissue and adjacent dermal tissue of the skin. To characterize IMP`'s ability to regulate the observed cellular infiltration through both complement derived and non-complement derived chemotactic factors, footpad and skin connective tissue of C3 knockout mice and footpad of MIP-1 α knockout mice received injections of CPV and CPV-IMP. In comparison to the matched control, significantly greater footpad specific swelling response was seen in C3 -/- mice injected with CPV. This indicates an important role for C3 in poxvirus pathogenesis. However, MIP-1 alpha -/- mice injected with CPV-IMP recovered earlier than mice injected with CPV alone. This indicates that the function of IMP in vivo in mice with a complete repertoire of immune components is to limit cellular infiltration by down regulating the complement derived chemotactic analphylotoxins, thereby modulating the inflammatory response contributing to a diminished tissue pathology and preservation of viral habitat.
Similar content being viewed by others
References
Miller CG, Shchelkunov SN, Kotwal GJ: Cowpox virus encoded homolog of the vaccinia virus complement control protein is an inflammation modulatory protein (IMP). Virology 229: 126–133, 1997
Kotwal GJ: The great escape: Immune evasion by pathogens. Immunologist 4/5: 157–164, 1996
Moss B: In: BN Fields, DM Knipe and PM Howley (eds). Fundamental virology. Lipincott-Raven Press, Philadelphia, 1996, pp 1163–1198
Miller CG, Justus DE, Jayaraman S, Kotwal GJ: Severe and prolonged inflammatory response to localized cowpox virus infection in footpads of C5-Deficient mice: Investigation of the role of host complement in poxvirus pathogenesis. Cell Immunol 162: 326–332, 1995
Kotwal GJ, Moss B: Vaccinia virus encodes two proteins that are structurally related to members of the plasma serine protease inhibitor superfamily. J Virol 63: 600–696, 1989
Ray CA, Black RA, Kronheim SR, Greenstreet TA, Sleath PR, Salvesen GS, Pickup DJ: Viral inhibition of inflammation: Cowpox virus encodes an inhibitor of the interleukin-1 converting enzyme. Cell 69: 597–694, 1992
Kotwal GJ, Moss B: Vaccinia virus encodes a secretory polypeptide structurally related to complement control proteins. Nature 335: 176–178, 1988
Kotwal GJ, Hugin AW, and Moss B: Mapping and insertional mutagenesis of a vaccinia virus gene encoding a 13,800-Da secreted protein. Virology 282: 689–698, 1989
Upton C, Mossman K, and McFadden G: Encoding of a homolog of the IFN-gamma receptor by myxoma virus. Science 258: 1369–1372, 1992
Massung RF, Esposito JJ, Liu L, Qi J, Utterback TR, Knight JC, Aubin L, Yuran TE, Parsons JM, Loparev VN, Selivanov NA, Cavallaro KF, Kerlavage AR, Mahy BWJ, Venter JC: Potential virulence determinants in terminal regions of variola smallpox virus genome. Nature 366: 748–751, 1993
Kotwal GJ, Isaacs SN, McKenzie R, Frank MM, Moss B: Inhibition of the complement cascade by the major secretory protein of vaccinia virus. Science 250: 827–830, 1990
McKenzie R, Kotwal GJ, Moss B, Hammer CH, Frank MM: Regulation of complement activity by vaccinia virus complement-control protein. J Inf Dis 166: 1245–1254, 1992
Isaacs SN, Kotwal GJ, Moss B: Vaccinia virus complement-control protein prevents antibody-dependent complement-enhanced neutralization of infectivity and contributes to virulence. Proc Natl Acad Sci USA 89: 628–632, 1992
Cook DN, Beck MA, Coffman TM, Kirby SL, Sheridan JF, Pragnell IB, Smithies O: Requirement of MIP-1 for an inflammatory response to viral infection. Science 269: 1583–1585, 1995
Li CY, Yam LT, Sun T: Modern modalities for the diagnosis of hematologic neoplasms, Igaku-Shoin, New York, 1996.
Kotwal GJ, Moss B: Analysis of a large cluster of nonessential genes deleted from a vaccinia virus terminal transposition mutant. Virology 167: 524–537, 1988
Palumbo GJ, Pickup DJ, Fredrickson TN, McIntyre LJ, Buller RML: Inhibition of an inflammatory response is mediated by a 38-kDa protein of cowpox virus. Virology 172: 262–273, 1989
Spriggs MK, Armitage RJ, Comeau MR, Strockbine L, Farrah T, McDuf B, Ulrich D, Alderson MR, Mullberg J, Cohen, JI: The extracellular domain of the Epstein-Barr Virus BZLF2 protein binds the HLA-DR chain and inhibits antigen presentation. J Virol 70: 5557–5563, 1996
Kotwal GJ: Microorganisms and their interaction with the immune system. J Leukocyte Biol 62: 415–429, 1997
Spriggs MK, Hruby DE, Maliszewski CR, Sims JE, Buller RML, VanSlyke J: Vaccinia and cowpox viruses encode a novel secreted interleukin-1-binding protein. Cell 71: 145–152, 1992
Alcami A, Higbee NC, Smith GL: Poxvirus conference 103(Abstract), 1994
Palumbo GJ, Buller RML, Glasgow WC: Multigenic evasion of inflammation by poxviruses. J Virol 68(3): 1737–1749, 1994
Buller RML, Chakrabarti S, Moss B, Fredrickson TN: Cell proliferative response to vaccinia virus is mediated by VGF. Virology 164: 182–192, 1988
Graham KA, Lalani AS, Macen JL, Ness TL, Barry M, Liu L-Y, Lucas A, Clark-Lewis I, Moyer RW, McFadden G: The T1/35 kDa family of poxvirus-secreted proteins bind chemokines and modulate leukocyte influx into virus-infected tissues. Virology 229: 12–24, 1997
Miller CG, Wellhausen S, Justus DE, Kotwal GJ: In: E Faist (ed). Cowpox virus IMP modulates the inflammatory response by restricting mononuclear cell infiltration in proceedings of the 4th International Congress on The Immune Consequences of Trauma, Shock and Sepsis. Monduzzi Editore, Bologna, Italy, 1997, pp 209–213
Kotwal GJ, Blasco R, Miller CG, Kuntz S, Jayaraman S, Shchelkunov SN: Strategies for Immunomodulation and evasion by microbes: Important consideration in the development of live vaccine. In: MM Albl, HH Peter (eds). Symp Immunol VII: Vaccination. Springer-Verlag, Berlin, Heidelberg, 1998, in press
Miller CG, Cook DN, Kotwal GJ: Two chemotactic factors C5a and MIP-1 alpha, dramatically alter the mortality from zymosan-induced multiple organ dysfunction syndrome (MODS): C5a contributes to MODS while MIP-1 alpha has a protective role. Mol Immunol 33: 1135–1137, 1996
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kotwal, G.J., Miller, C.G. & Justus, D.E. The inflammation modulatory protein (IMP) of cowpox virus drastically diminishes the tissue damage by down-regulating cellular infiltration resulting from complement activation. Mol Cell Biochem 185, 39–46 (1998). https://doi.org/10.1023/A:1006844624825
Issue Date:
DOI: https://doi.org/10.1023/A:1006844624825